Get the Stockscreener App
1.4848
1.62%
0.0048
After Hours:
1.47
-0.0148
-1.00%
60 Degrees Pharmaceuticals Inc stock is traded at $1.4848, with a volume of 226.85K.
It is up +1.62% in the last 24 hours and down -7.73% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
See More
Previous Close:
$1.48
Open:
$1.48
24h Volume:
226.85K
Relative Volume:
0.21
Market Cap:
$4.12M
Revenue:
$1.41M
Net Income/Loss:
$-7.36M
P/E Ratio:
-0.1404
EPS:
-10.5747
Net Cash Flow:
$-7.07M
1W Performance:
+6.67%
1M Performance:
-7.73%
6M Performance:
-64.19%
1Y Performance:
-81.29%
1-Day Range:
$1.46
$1.60
1-Week Range:
$1.3582
$1.60
52-Week Range:
$1.29
$14.68
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.55 | 3.94M | 1.41M | -7.36M | -7.07M | -10.57 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial - Investing.com
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis - Stock Titan
60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading - Bez Kabli
60 Degrees Pharmaceuticals (SXTP) Holds Near Support After Minor DeclineFlat Correction - Newser
60 Degrees Pharmaceuticals (SXTP) Dips 1.34% as Shares Test Support LevelSupport Level Bounce - Newser
60 Degrees Pharmaceuticals, Inc.Warrant (NQ: SXTPW - The Chronicle-Journal
SXTP Stock Price, Quote & Chart | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
SXTP Downgraded by HC Wainwright & Co. -- New Rating: Neutral - GuruFocus
60 Degrees Pharm Cut to Neutral From Buy by HC Wainwright & Co. - Moomoo
H.C. Wainwright Downgrades 60 Degrees Pharmaceuticals(SXTP.US) to Hold Rating - Moomoo
60 Degrees Pharmaceuticals (NASDAQ: SXTP) director files initial Form 3 insider report - Stock Titan
60 Degrees Pharmaceuticals, Inc. Files Form 8-K with SEC – Company Details, NASDAQ Listing, and Compliance Highlights - Minichart
60 Degrees Pharmaceuticals appoints Eric Francois to board of directors - Investing.com
60 Degrees Pharmaceuticals appoints Eric Francois to board - TradingView
Eric Francois joins 60 Degrees Pharmaceuticals (SXTP) board with deep biotech finance background - Stock Titan
Knight Therapeutics (TSX: GUD) reports exit from SXTP, 0 shares as of Mar 31, 2026 - Stock Titan
60 Degrees Pharmaceuticals, Inc. Q1 2026 Financial Results: Net Loss, Operating Expenses, and Key Financial Highlights - Minichart
CVI/Heights report 7.0% stake in 60 Degrees (NASDAQ: SXTP) - Stock Titan
60 Degrees Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet
60 Degrees Pharm 1Q Rev $162,000 >SXTP - Moomoo
Tiny $162K sales, $2.21M loss: 60 Degrees Pharma Q1 2026 - Stock Titan
60 Degrees Pharmaceuticals 1Q 2026: Revenue $162.09K, EPS ($1.28) — 10-Q Summary - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) posts Q1 2026 loss and flags going concern risk - Stock Titan
MSN Money - MSN
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
60 Degrees reports shared 9.1% stake (SXTP) from warrants and holdings - Stock Titan
SXTP Q1'26 Earnings: EPS estimate is (0.76) USD - TradingView
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ChartMill
The biggest catalyst for 60 Degrees (SXTP) nobody is watching (Momentum Fading) 2026-05-08Late Breakout - Newser
60 Degrees Pharmaceuticals (SXTP) price target decreased by 19.89% to 14.38 - MSN
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
60 Degrees Pharmaceuticals Inc. (SXTP) upgraded to buy: Here's what you should know - MSN
Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up - MSN
60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk - MSN
Is 60 Degrees (SXTP) stock holding key zones | Q4 2025: EPS Misses ViewsNCAV - Newser
60 Degrees (SXTP) Stock: Investment Potential Review (Tick Up) 2026-04-20Trending Entry Points - Xã Châu Thành
60 Degrees Pharmaceuticals, Inc. Partners with Runway Health to Offer ARAKODA® for Convenient Online Malaria Prevention - Quiver Quantitative
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website - The Manila Times
Once-weekly malaria preventive moves online for U.S. travelers - Stock Titan
SXTP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) - Minichart
Sentiment Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesMarket Performance Recap & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Targets Report: Will 60 Degrees Pharmaceuticals Inc benefit from sector rotationIPO Watch & Weekly Breakout Watchlists - baoquankhu1.vn
Macro Review: Whats the fair value of 60 Degrees Pharmaceuticals Inc stockEarnings Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
SXTPW | 60 Degrees Pharmaceuticals, Inc. Insider Trading - Quiver Quantitative
Is 60 Degrees (SXTP) Stock in a Downtrend | Price at $1.71, Down 4.75%Expert Momentum Signals - Newser
CEO Change: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals Announces 2025 Annual Results - ADVFN
Earnings Miss: Will 60 Degrees Pharmaceuticals Inc Equity Warrant benefit from geopolitical trends2026 Retail & AI Enhanced Trading Signals - baoquankhu1.vn
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
1.49%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):